Instil Bio Inc. (TIL)
NASDAQ: TIL
· Real-Time Price · USD
28.85
1.01 (3.63%)
At close: Aug 18, 2025, 3:59 PM
29.00
0.52%
After-hours: Aug 18, 2025, 04:41 PM EDT
3.63% (1D)
Bid | 26.09 |
Market Cap | 194.76M |
Revenue (ttm) | n/a |
Net Income (ttm) | -78.03M |
EPS (ttm) | -12.91 |
PE Ratio (ttm) | -2.23 |
Forward PE | -2.13 |
Analyst | Buy |
Ask | 29.98 |
Volume | 93,165 |
Avg. Volume (20D) | 326,011 |
Open | 27.89 |
Previous Close | 27.84 |
Day's Range | 27.13 - 29.48 |
52-Week Range | 10.06 - 92.00 |
Beta | 2.17 |
Analyst Forecast
According to 0 analyst ratings, the average rating for TIL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+8.57%
Instil Bio shares are trading higher after the com...
Unlock content with
Pro Subscription
7 months ago
+14.84%
Instil Bio shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $11 to $52.

2 months ago · seekingalpha.com
Instil Bio: Second-Half 2025 AXN-2510 Data Could Mark Another PD-1/VEGF SuccessKey catalyst: Phase 2 data from China in first-line NSCLC expected in 2H 2025, with enrollment completion projected for Q3 2025. The global non-small cell lung cancer therapeutics market size is proje...